FX006
FX006-2018-015
Phase 3 small_molecule terminated
Quick answer
FX006 for Osteoarthritis, Hip is a Phase 3 program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pacira BioSciences
- Indication
- Osteoarthritis, Hip
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated